HTA - 16/56/04

Nivolumab for treating Hodgkin's lymphoma (after ASCT and brentuximab vedotin) ID972

Project title: Nivolumab for treating Hodgkin's lymphoma (after ASCT and brentuximab vedotin) ID972

Call to action: 16/56 Batch 49

Research type: Evidence Synthesis

Chief investigator: Dr Joanna Picot

Contractor: University of Southampton

Cost: £65,625.00

Started: November 2016 | Status: Project complete

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.